These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 20375116)

  • 1. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
    Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
    Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy].
    Wang S; Li Y; Huang YJ
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephron-deficient Fvb mice develop rapidly progressive renal failure and heavy albuminuria involving excess glomerular GLUT1 and VEGF.
    Wang Y; Heilig KO; Minto AW; Chen S; Xiang M; Dean DA; Geiger RC; Chang A; Pravtcheva DD; Schlimme M; Deb DK; Wang Y; Heilig CW
    Lab Invest; 2010 Jan; 90(1):83-97. PubMed ID: 19918242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inducible overexpression of sFlt-1 in podocytes ameliorates glomerulopathy in diabetic mice.
    Ku CH; White KE; Dei Cas A; Hayward A; Webster Z; Bilous R; Marshall S; Viberti G; Gnudi L
    Diabetes; 2008 Oct; 57(10):2824-33. PubMed ID: 18647955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of Mafb in podocytes protects against diabetic nephropathy.
    Morito N; Yoh K; Ojima M; Okamura M; Nakamura M; Hamada M; Shimohata H; Moriguchi T; Yamagata K; Takahashi S
    J Am Soc Nephrol; 2014 Nov; 25(11):2546-57. PubMed ID: 24722438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of PTEN promotes podocyte cytoskeletal rearrangement, aggravating diabetic nephropathy.
    Lin J; Shi Y; Peng H; Shen X; Thomas S; Wang Y; Truong LD; Dryer SE; Hu Z; Xu J
    J Pathol; 2015 May; 236(1):30-40. PubMed ID: 25641678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.
    Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valsartan slows the progression of diabetic nephropathy in db/db mice via a reduction in podocyte injury, and renal oxidative stress and inflammation.
    Zhou G; Cheung AK; Liu X; Huang Y
    Clin Sci (Lond); 2014 May; 126(10):707-20. PubMed ID: 24195695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice.
    Kosugi T; Nakayama T; Li Q; Chiodo VA; Zhang L; Campbell-Thompson M; Grant M; Croker BP; Nakagawa T
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F609-16. PubMed ID: 20015944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of VEGF-A in podocytes of adult mice causes glomerular disease.
    Veron D; Reidy KJ; Bertuccio C; Teichman J; Villegas G; Jimenez J; Shen W; Kopp JB; Thomas DB; Tufro A
    Kidney Int; 2010 Jun; 77(11):989-99. PubMed ID: 20375978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice.
    Yokoi H; Mukoyama M; Mori K; Kasahara M; Suganami T; Sawai K; Yoshioka T; Saito Y; Ogawa Y; Kuwabara T; Sugawara A; Nakao K
    Kidney Int; 2008 Feb; 73(4):446-55. PubMed ID: 18075496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glomerular mesangial cell and podocyte injuries in diabetic nephropathy.
    Tung CW; Hsu YC; Shih YH; Chang PJ; Lin CL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():32-37. PubMed ID: 30298646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice.
    Zhang H; Nair V; Saha J; Atkins KB; Hodgin JB; Saunders TL; Myers MG; Werner T; Kretzler M; Brosius FC
    Kidney Int; 2017 Oct; 92(4):909-921. PubMed ID: 28554737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice.
    Nadarajah R; Milagres R; Dilauro M; Gutsol A; Xiao F; Zimpelmann J; Kennedy C; Wysocki J; Batlle D; Burns KD
    Kidney Int; 2012 Aug; 82(3):292-303. PubMed ID: 22475818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.